3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Dexamethasone
363
Bortezomib
232
Lenalidomide
202
Cyclophosphamide
174
Melphalan
154
Calcium Dobesilate
107
Peripheral Blood Stem Cell Transplantation
92
fludarabine phosphate
84
Thalidomide
81
Filgrastim
71
carfilzomib
68
pomalidomide
66
Granulocyte Colony-Stimulating Factor
60
Mycophenolic Acid
59
Busulfan
57
daratumumab
55
Whole-Body Irradiation
54
Tacrolimus
51
ixazomib
50
Prednisone
50
Cyclosporine
49
fludarabine
46
Antilymphocyte Serum
35
Etoposide
30
dexamethasone acetate
29
Methotrexate
29
plerixafor
27
Radiotherapy
26
Doxorubicin
26
dexamethasone 21-phosphate
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Multiple Myeloma
×
Molecular Diagnostic Techniques
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled